Insights+ KOL Articles: The New Normal and Covid-19 Vaccine Development
Since the virus outbreak in China, all eyes are on the most awaited Covid-19 vaccine offering a glimmer of hope. Abide by social
[Read More...]
Development
Ovid Therapeutics and University of Connecticut Collaborate to Accelerate the Development of OV101 (gaboxadol) for Angelman Syndrome
Shots: Ovid will collaborate with UConn’s Stormy J. Chamberlain and secures exclusive access to identified genetic sequences for shRNA-based therapy. Ovid plans to
[Read More...]
Samsung Biologics Signs Multi-Product Development and Manufacturing Agreement with ImmuneOncia
Shots: The two companies expand their 2018 agreement to develop and manufacture five candidates from ImmuneOncia’s pipeline. The partners expand the collaboration to
[Read More...]
Sanofi and MD Anderson Sign a Five-Year Pact to Expedite Oncology Research and Development
Shots: Sanofi and MD Anderson collaborated for 5yrs. to ramp up the development of investigational treatments, including targeted and immune-therapies for oncology patients.
[Read More...]
Samsung Biologics Expands its Development Partnership with STCube for STM418
Shots: Samsung Biologics to offer CDO services from cell line development, process development, non-clinical & clinical material manufacturing, to IND submission for global
[Read More...]
Merck Collaborates with Yumanity to Accelerate the Development of Two Therapies Targeting Neurodegenerative Diseases
Shots: Yumanity will receive $500M upfront and milestones along with royalties on net sales of therapies, in exchange Merck to get an exclusive
[Read More...]
BARDA to Fund $1B to AstraZeneca for Research and Development of Novel COVID-19 Vaccines
Shots: The $1B support is for the development, production and delivery of the vaccine with its initiation in H2’20 including a P-III trial
[Read More...]
Roche Acquires Stratos Genomics to Advance the Development of Nanopore Sequencer
Shots: Roche has acquired Stratos Genomics to facilitate the development of its nanopore sequencer to provide the healthcare community and ultimately patients with
[Read More...]
Insights+ COVID-19 Deals (Part II): Biopharma Vaccine Development
The recent emergence of the coronavirus SARS-CoV-2 and the COVID-19 pandemic has spurred global healthcare and life sciences companies, as well as government
[Read More...]
Pfizer Signs a Development and Commercialization Agreement with Valneva for Lyme Disease Vaccine
Shots: Valneva to receive $308M in cash including $130M up front, $35M as development milestones and $143M as early commercialization milestones and will
[Read More...]